Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion
JAMA Intern Med
.
2013 Mar 25;173(6):475-6.
doi: 10.1001/jamainternmed.2013.2176.
Authors
Laurent Hocqueloux
,
Asier Saez-Cirion
,
Christine Rouzioux
PMID:
23529554
DOI:
10.1001/jamainternmed.2013.2176
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Retroviral Agents / therapeutic use*
Female
HIV Infections / drug therapy*
HIV Seropositivity / drug therapy*
HIV-1 / immunology*
Humans
Male
Substances
Anti-Retroviral Agents